Measurment of GFR by Nasal Sensors
This study has been completed.
Sponsor:
Rambam Health Care Campus
Information provided by:
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT01274169
First received: January 10, 2011
Last updated: NA
Last verified: February 2008
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
to measure kidney function by measuring blood creatinine and to compare it to the measurment of GFR by Nanotechnology
| Condition |
|---|
|
Measure GFR by Nasal Sensor |
| Study Type: | Observational |
Further study details as provided by Rambam Health Care Campus:
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
volunteers subjects with different stages of CKD
Criteria
Inclusion Criteria:
adults between 18-70 yrs
Exclusion Criteria:
subject under 18
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| Responsible Party: | Ministry of health israel |
| ClinicalTrials.gov Identifier: | NCT01274169 History of Changes |
| Other Study ID Numbers: | NANOCTIL |
| Study First Received: | January 10, 2011 |
| Last Updated: | January 10, 2011 |
| Health Authority: | United States: Food and Drug Administration |
ClinicalTrials.gov processed this record on October 18, 2012
